Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • SeqNerd
    Junior Member
    • Jun 2011
    • 6

    no dual indices on NextSeq 500 (yet)

    There aren't a whole lot of NextSeq 500s in the wild yet, but for those lucky among you who have one, are expecting one, or hoping to run your libraries on one soon, please be aware that dual indices are not supported as of this writing. So pick your TruSeq/Nextera index combinations with care.

    To quote Illumina over the phone: "we're working on it".
  • BBthekid007
    Junior Member
    • Feb 2010
    • 7

    #2
    Custom indexing is a no-go as well -- only 'official' Illumina index sequences can be used. As with dual indexing, they're "working on it".

    One more note of caution: unlike the MiSeq, where longer-than-officially-supported reads are possible, the NextSeq will not allow runs that exceed the stated capacity of the reagent kits. We regularly do 350x300 or PE325 with the MiSeq's 600-cycle kit, but there's no way to do that with the NextSeq.

    Comment

    • nucacidhunter
      Jafar Jabbari
      • Jan 2013
      • 1250

      #3
      Quote from Illumina website:
      "The TruSeq Dual Index Sequencing Primer Box supports the preparation of Nextera libraries for dual-indexed sequencing on the NextSeq 500, HiSeq 1000, HiSeq 2000, HiScanSQ, or Genome Analyzer instruments."

      Comment

      • avo
        Member
        • Sep 2013
        • 14

        #4
        Originally posted by BBthekid007 View Post
        We regularly do 350x300 or PE325 with the MiSeq's 600-cycle kit, but there's no way to do that with the NextSeq.
        Do you do those 350x300 or PE325 reads with the standard 600-cycle kit, where the extra cycles derive from not reading indices and excessive reagents or is it some sort of "hacked" cartridge (like for the V2 kits)?

        Comment

        • bryanbriney
          Junior Member
          • May 2014
          • 8

          #5
          Originally posted by avo View Post
          Do you do those 350x300 or PE325 reads with the standard 600-cycle kit, where the extra cycles derive from not reading indices and excessive reagents or is it some sort of "hacked" cartridge (like for the V2 kits)?
          We've done 350x310 runs with a standard 600-cycle kit, including an 8bp index read. Based on the amount of reagents left after a 350x310 run, you could probably go up to 350x325 with an index.

          Comment

          • avo
            Member
            • Sep 2013
            • 14

            #6
            Did any of these runs use the new MCS Version 2.4.1.3?
            To me it triggers an error that the number of cycles is out of range for the used cartridge.

            Maybe the number of cycles is now limited in the new version of MCS?

            Comment

            • supuamina
              Junior Member
              • Oct 2014
              • 2

              #7
              I would love to hear more feedback on anyone who currently uses a Nextseq 500. What are the likes and dislikes of this instrument?

              Comment

              • bryanbriney
                Junior Member
                • May 2014
                • 8

                #8
                We've done about two dozen runs and have been really happy with our NextSeq. Total throughput regularly exceeds Illumina's specs (not uncommon for us to get ~500M reads in high-output mode). We also have MiSeqs, and read quality between the two instruments is roughly similar -- we only do PE300 reads on the MiSeq, so we can't do a direct quality comparison. In our case, which involves sequencing low diversity libraries, we haven't had any issues with the 2-color vs. 4-color sequencing.

                Any specific questions you'd like me to address?

                Comment

                • supuamina
                  Junior Member
                  • Oct 2014
                  • 2

                  #9
                  What are the Q scores of the sequences coming off the NextSeq 500 compared to those of MiSeq. What are the error rates of the NextSeq 500 so if looking for a MAF>0.5% in an Onco sample?

                  Comment

                  • Brian Bushnell
                    Super Moderator
                    • Jan 2014
                    • 2709

                    #10
                    You may want to look at this thread. The NextSeq quality scores are not currently comparable to MiSeq/HiSeq.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                      by SEQadmin2


                      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                      The systematic characterization of the human proteome has
                      ...
                      07-20-2026, 11:48 AM
                    • SEQadmin2
                      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                      by SEQadmin2



                      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                      ...
                      07-09-2026, 11:10 AM
                    • SEQadmin2
                      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                      by SEQadmin2



                      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                      07-08-2026, 05:17 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, 07-24-2026, 12:17 PM
                    0 responses
                    20 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-23-2026, 11:41 AM
                    0 responses
                    19 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-20-2026, 11:10 AM
                    0 responses
                    25 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-13-2026, 10:26 AM
                    0 responses
                    38 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...